<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mpph" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mpph</book-part-id>
      <title-group>
        <title>MPPH Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: Megalencephaly-Postaxial Polydactyly-Polymicrogyria-Hydrocephalus Syndrome, Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mirzaa</surname>
            <given-names>Ghayda</given-names>
          </name>
          <degrees>MD, FAAP, FACMG</degrees>
          <aff>Seattle Children&#x02019;s Research Institute<break/>Seattle, Washington</aff>
          <email>gmirzaa@uw.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>17</day>
          <month>11</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="merrf" document-type="chapter">MERRF</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="mpv17-mtdep" document-type="chapter"><italic toggle="yes">MPV17</italic>-Related Hepatocerebral Mitochondrial DNA Depletion Syndrome</related-object>
      <abstract id="mpph.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The MPPH syndrome is a developmental brain disorder characterized by megalencephaly (brain overgrowth) with the cortical malformation bilateral perisylvian polymicrogyria (BPP). At birth the occipital frontal circumference (OFC) ranges from normal to 6 standard deviations (SD) above the mean for age, sex, and gestational age; in older individuals the range is from 3 to 10 SD above the mean. A variable degree of ventriculomegaly is seen in almost all children with MPPH syndrome; nearly 50% of those have frank hydrocephalus. Neurologic problems associated with BPP include oromotor dysfunction (100%), epilepsy (50%), and mild to severe intellectual disability (100%). Postaxial hexadactyly occurs in 50% of individuals with MPPH syndrome.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The clinical diagnosis of MPPH syndrome can be established in individuals with the two core features: megalencephaly and BPP. The molecular diagnosis of MPPH syndrome is established in a proband with some of the suggestive clinical and imaging features and the identification of a heterozygous pathogenic variant in one of three genes: <italic toggle="yes">AKT3</italic>, <italic toggle="yes">CCND2</italic>, or <italic toggle="yes">PIK3R2</italic>. While most individuals with MPPH syndrome have a germline pathogenic variant in one of these three genes, some have a somatic mosaic pathogenic variant (most commonly reported in <italic toggle="yes">PIK3R2</italic>).</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Hydrocephalus warrants early neurosurgical intervention. Oromotor difficulties, developmental delays, and epilepsy are treated as per usual clinical care standards.</p>
          <p><italic toggle="yes">Surveillance:</italic> Follow up with a pediatric neurologist, at least every six months until age six years, and yearly thereafter. Brain MRI to detect hydrocephalus and/or cerebellar tonsillar ectopia is provisionally recommended every six months from birth to age two years, and yearly from age two to six years. In older individuals, the frequency should be determined within the context of prior brain imaging findings and clinical findings. Long-term neurologic follow up is warranted for epilepsy. Routine follow up with a developmental pediatrician given the high risk of developmental delays and/or intellectual disability.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>MPPH syndrome is inherited in an autosomal dominant manner. Most individuals with MPPH syndrome have the disorder as the result of a <italic toggle="yes">de novo AKT3</italic>, <italic toggle="yes">CCND2</italic>, or <italic toggle="yes">PIK3R2</italic> pathogenic variant. In one family, vertical transmission of a <italic toggle="yes">PIK3R2</italic> pathogenic variant was observed; in two families, parental germline mosaicism for a <italic toggle="yes">PIK3R2</italic> pathogenic variant seemed likely (given recurrence of MPPH syndrome in sibs and failure to detect the pathogenic variant in DNA isolated from parental blood samples). Each child of an individual with a germline pathogenic variant has a 50% chance of inheriting the pathogenic variant. Once the <italic toggle="yes">AKT3</italic>, <italic toggle="yes">CCND2</italic>, or <italic toggle="yes">PIK3R2</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk for MPPH syndrome and preimplantation genetic diagnosis are possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mpph.Diagnosis">
        <title>Diagnosis</title>
        <sec id="mpph.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>MPPH syndrome <bold>should be suspected</bold> in individuals with the following clinical and imaging findings [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2004.353">Mirzaa et al 2004</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>]. Note: Findings shown in <bold>bold</bold> are core features.</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Macrocephaly</bold>
<bold>or</bold>
<bold>megalencephaly</bold> (occipito-frontal circumference &#x02265;2 SD above the mean); onset either prenatally or postnatally</p>
            </list-item>
            <list-item>
              <p>Postaxial polydactyly of one or more extremities</p>
            </list-item>
            <list-item>
              <p>Hypotonia</p>
            </list-item>
            <list-item>
              <p>Early-onset epilepsy</p>
            </list-item>
            <list-item>
              <p>Intellectual disability</p>
            </list-item>
            <list-item>
              <p>Oromotor dysfunction</p>
            </list-item>
          </list>
          <p>
            <bold>Imaging findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cortical brain malformations, particularly bilateral perisylvian polymicrogyria</bold> (BPP)</p>
            </list-item>
            <list-item>
              <p>Progressive ventriculomegaly leading to hydrocephalus</p>
            </list-item>
            <list-item>
              <p>Cerebellar tonsillar ectopia or Chiari malformations</p>
            </list-item>
            <list-item>
              <p>Thick corpus callosum (or mega corpus callosum)</p>
            </list-item>
          </list>
        </sec>
        <sec id="mpph.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p><bold>The clinical diagnosis</bold> of MPPH syndrome <bold>can be established</bold> in individuals with the two core features: megalencephaly and polymicrogyria).</p>
          <p><bold>The molecular diagnosis</bold> of MPPH syndrome <bold>is established</bold> in a proband with some of the suggestive clinical and imaging features and the identification of a heterozygous pathogenic variant in one of three genes: <italic toggle="yes">AKT3</italic>, <italic toggle="yes">CCND2</italic>, or <italic toggle="yes">PIK3R2</italic> (<xref ref-type="table" rid="mpph.T.molecular_genetic_testing_used_in">Table 1</xref>). While most individuals with MPPH syndrome have a germline (i.e., constitutional) pathogenic variant in one of these three genes, some individuals have been reported with a somatic mosaic pathogenic variant in one of these genes (most commonly <italic toggle="yes">PIK3R2)</italic>.</p>
          <p>Note that failure to detect either a germline or somatic mosaic pathogenic variant in one of these three genes in a proband does not exclude a clinical diagnosis of MPPH syndrome in individuals with the two core clinical and imaging features.</p>
          <p>Molecular genetic testing approaches used to identify germline and somatic pathogenic variants can include a combination of <bold>serial single-gene testing</bold>, <bold>chromosomal microarray analysis (CMA</bold>), and use of a <bold>multi-gene panel</bold>.</p>
          <sec id="mpph.FirstTier_Testing">
            <title>First-Tier Testing</title>
            <p><bold>Serial single-gene testing</bold> can be considered in order of the likelihood of identifying a germline pathogenic variant (<xref ref-type="table" rid="mpph.T.molecular_genetic_testing_used_in">Table 1</xref>). Sequence analysis of the gene of interest is performed first.</p>
          </sec>
          <sec id="mpph.SecondTier_Testing">
            <title>Second-Tier Testing</title>
            <p><bold>For somatic mosaicism.</bold> If no germline pathogenic variant is found in any of the three genes, sequence analysis for <italic toggle="yes">AKT3</italic> or <italic toggle="yes">PIK3R2</italic> with methods to detect somatic mosaicism may be warranted and/or testing for a large duplication of 1q43-q44 that includes <italic toggle="yes">AKT3</italic>.</p>
            <list list-type="bullet">
              <list-item>
                <p>Sequence analysis of DNA derived from saliva or skin (whether visibly affected or not) may detect a pathogenic variant not detected in DNA isolated from blood.</p>
              </list-item>
              <list-item>
                <p>Sensitivity to detect low-level mosaicism of a somatic pathogenic variant is theoretically greatest using massively parallel sequencing (also known as next-generation sequencing) in tissues other than blood, and in particular will be of high yield when analyzing affected tissues</p>
              </list-item>
            </list>
            <p><bold>For duplication of 1q43-q44 that includes <italic toggle="yes">AKT3</italic>.</bold> Because not all gene-targeted deletion/duplication methods are designed to size large CNVs, CMA is the most appropriate for detection of this duplication.</p>
          </sec>
          <sec id="mpph.Testing_to_Consider">
            <title>Testing to Consider</title>
            <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">AKT3, CCND2</italic>, <italic toggle="yes">PIK3R2,</italic> and other genes of interest (see <xref ref-type="sec" rid="mpph.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered to detect germline and somatic variants in the MPPH-related genes. Note: (1) The genes included and the sensitivity of multi-gene panels vary by laboratory and over time. (2) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests. (3) Somatic mosaicism for variants in the three MPPH-related genes may not be detected by all commercially available multi-gene panels due primarily to the inability to test tissues other than blood (e.g., skin or buccal cells) and/or technical limitations in detecting low-level mosaicism; thus, clinicians considering use of a multi-gene panel need to select a panel specifically optimized to detect mosaicism for the three MPPH-related genes.</p>
            <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            <table-wrap id="mpph.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Molecular Genetic Testing Used in MPPH Syndrome</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2">Number of Persons with Molecularly Confirmed MPPH Syndrome Attributed to a Pathogenic Variant in This Gene&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Number of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by This Method</th>
                  </tr>
                  <tr>
                    <th headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup></th>
                    <th headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CMA&#x000a0;<sup>5</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">AKT3</italic>
                    </td>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">12/41</td>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">6/12</td>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">6/12&#x000a0;<sup>6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">CCND2</italic>
                    </td>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">12/41</td>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">12/12</td>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">PIK3R2</italic>
                    </td>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">17/41</td>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">17/17&#x000a0;<sup>7,&#x000a0;8</sup></td>
                    <td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mpph.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="mpph" object-id="mpph.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="mpph.TF.1.2">
                  <label>2. </label>
                  <p>References for the 41 patients with a molecularly confirmed diagnosis: <xref ref-type="bibr" rid="mpph.REF.mirzaa.2012.269">Mirzaa et al [2012]</xref>, <xref ref-type="bibr" rid="mpph.REF.poduri.2012.41">Poduri et al [2012]</xref>, <xref ref-type="bibr" rid="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al [2012]</xref>, <xref ref-type="bibr" rid="mpph.REF.wang.2013.2016">Wang et al [2013]</xref>, <xref ref-type="bibr" rid="mpph.REF.chung.2014.1868">Chung et al [2014]</xref>, <xref ref-type="bibr" rid="mpph.REF.jamuar.2014.733">Jamuar et al [2014]</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2014.510">Mirzaa et al [2014]</xref>, <xref ref-type="bibr" rid="mpph.REF.nakamura.2014.396">Nakamura et al [2014]</xref>, <xref ref-type="bibr" rid="mpph.REF.tapper.2014.e86940">Tapper et al [2014]</xref>, <xref ref-type="bibr" rid="mpph.REF.conti.2015.241">Conti et al [2015]</xref>, <xref ref-type="bibr" rid="mpph.REF.harada.2015.465">Harada et al [2015]</xref>, <xref ref-type="bibr" rid="mpph.REF.nellist.2015.467">Nellist et al [2015]</xref>, <xref ref-type="bibr" rid="mpph.REF.hemming.2016.458">Hemming et al [2016]</xref>, <xref ref-type="bibr" rid="mpph.REF.terrone.2016.1359">Terrone et al [2016]</xref>. Note that the other 23 individuals with a clinical diagnosis of MPPH syndrome did not undergo the complete molecular and cytogenetic testing required to detect the range of causative germline and somatic pathogenic variants.</p>
                </fn>
                <fn id="mpph.TF.1.3">
                  <label>3. </label>
                  <p>See <xref ref-type="sec" rid="mpph.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="mpph.TF.1.4">
                  <label>4. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="mpph.TF.1.5">
                  <label>5. </label>
                  <p>Chromosomal microarray analysis (CMA) using oligonucleotide arrays or SNP arrays. CMA designs in current clinical use target the 1q44 region.</p>
                </fn>
                <fn id="mpph.TF.1.6">
                  <label>6. </label>
                  <p>Duplications of 1q43-q44, which include <italic toggle="yes">AKT3</italic>, are detectable by CMA and cause macrocephaly and intellectual disability [<xref ref-type="bibr" rid="mpph.REF.chung.2014.1868">Chung et al 2014</xref>, <xref ref-type="bibr" rid="mpph.REF.wang.2013.2016">Wang et al 2013</xref>, <xref ref-type="bibr" rid="mpph.REF.hemming.2016.458">Hemming et al 2016</xref>]. Somatic duplication of this locus has been identified in individuals with hemimegalencephaly and focal cortical dysplasia [<xref ref-type="bibr" rid="mpph.REF.poduri.2012.41">Poduri et al 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.jamuar.2014.733">Jamuar et al 2014</xref>, <xref ref-type="bibr" rid="mpph.REF.conti.2015.241">Conti et al 2015</xref>]. Although these large duplications would be detected by gene-targeted deletion/duplication assays, some methods would be unable to size the duplication.</p>
                </fn>
                <fn id="mpph.TF.1.7">
                  <label>7. </label>
                  <p>Mosaicism for a <italic toggle="yes">PIK3R2</italic> pathogenic variant has been reported in individuals with MPPH syndrome [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>].</p>
                </fn>
                <fn id="mpph.TF.1.8">
                  <label>8. </label>
                  <p>Most individuals with a <italic toggle="yes">PIK3R2</italic> pathogenic variant have the same recurrent <xref ref-type="table" rid="mpph.T.pik3r2_pathogenic_variants_discus">p.Gly373Arg</xref> variant. Only three other <italic toggle="yes">PIK3R2</italic> pathogenic variants have been reported to date [<xref ref-type="bibr" rid="mpph.REF.nakamura.2014.396">Nakamura et al 2014</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>, <xref ref-type="bibr" rid="mpph.REF.terrone.2016.1359">Terrone et al 2016</xref>].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec id="mpph.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="mpph.Clinical_Description">
          <title>Clinical Description</title>
          <p>The MPPH syndrome is a developmental brain disorder characterized by megalencephaly (brain overgrowth) with the cortical malformation bilateral perisylvian polymicrogyria. Males and females are affected similarly.</p>
          <p>To date 62 individuals with features of MPPH syndrome have been reported with either a clinical diagnosis (presence of the two core clinical and imaging findings: megalencephaly and polymicrogyria) , and/or a molecularly confirmed diagnosis (<xref ref-type="table" rid="mpph.T.molecular_genetic_testing_used_in">Table 1</xref>) [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2004.353">Mirzaa et al 2004</xref>, <xref ref-type="bibr" rid="mpph.REF.colombani.2006.466">Colombani et al 2006</xref>, <xref ref-type="bibr" rid="mpph.REF.garavelli.2007.200">Garavelli et al 2007</xref>, <xref ref-type="bibr" rid="mpph.REF.tohyama.2007.148">Tohyama et al 2007</xref>, <xref ref-type="bibr" rid="mpph.REF.pisano.2008.916">Pisano et al 2008</xref>, <xref ref-type="bibr" rid="mpph.REF.tore.2009.1620">Tore et al 2009</xref>, <xref ref-type="bibr" rid="mpph.REF.verkerk.2010.1488">Verkerk et al 2010</xref>, <xref ref-type="bibr" rid="mpph.REF.osterling.2011.370">Osterling et al 2011</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.kariminejad.2013.651">Kariminejad et al 2013</xref>, <xref ref-type="bibr" rid="mpph.REF.zamora.2013">Zamora &#x00026; Roberts 2013</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</xref>, <xref ref-type="bibr" rid="mpph.REF.nakamura.2014.396">Nakamura et al 2014</xref>, <xref ref-type="bibr" rid="mpph.REF.tapper.2014.e86940">Tapper et al 2014</xref>, <xref ref-type="bibr" rid="mpph.REF.demir.2015.381">Demir et al 2015</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>, <xref ref-type="bibr" rid="mpph.REF.nellist.2015.467">Nellist et al 2015</xref>, <xref ref-type="bibr" rid="mpph.REF.terrone.2016.1359">Terrone et al 2016</xref>].</p>
          <sec id="mpph.Neurologic_Findings">
            <title>Neurologic Findings</title>
            <p><bold>Megalencephaly (brain overgrowth).</bold> Most individuals with MPPH syndrome reported to date have congenital or early postnatal megalencephaly (i.e., rapidly progressive megalencephaly within the first year of life).</p>
            <p>Occipital frontal circumference (OFC) at birth ranges from normal to 6 SD above the mean for age, sex, and gestational age.</p>
            <p>Later OFCs range from 3 to 10 SD above the mean.</p>
            <p>In individuals with MPPH syndrome who develop hydrocephalus, brain overgrowth persists after surgical intervention (e.g., neurosurgical shunting), an observation consistent with true brain overgrowth [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            <p><bold>Cortical malformations.</bold> To date, all individuals with MPPH syndrome have cortical brain malformations, particularly polymicrogyria (PMG). In almost all instances, the PMG is bilateral perisylvian polymicrogyria (BPP) and is largely symmetric. BPP is associated with neurologic problems that can include oromotor dysfunction, epilepsy, and intellectual disability.</p>
            <p><bold>Ventriculomegaly and hydrocephalus.</bold> Variable degrees of ventriculomegaly are seen in almost all children with MPPH syndrome. Nearly 50% of reported individuals with MPPH syndrome have frank hydrocephalus requiring neurosurgical placement of a shunt. Based on limited retrospective data, the risk for hydrocephalus and/or cerebellar tonsillar ectopia with low brain stem or high spinal cord compression appears to be highest in the first two years of life [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            <p><bold>Oromotor dysfunction,</bold> including expressive language or speech delay, difficulties handing oral secretions (with profuse drooling), and dysphagia is seen in most individuals with MPPH syndrome. These features are largely attributed to (and well-known to occur with) bilateral perisylvian polymicrogyria [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>].</p>
            <p><bold>Epilepsy.</bold> Approximately 50% of individuals with MPPH syndrome have early-onset epilepsy. Epilepsy types range from focal to generalized. Eight children with infantile spasms have been reported. Epilepsy may be refractory to several antiepileptic drugs. One individual with an <italic toggle="yes">AKT3</italic> pathogenic variant had severe refractory infantile spasms that responded to a ketogenic diet [<xref ref-type="bibr" rid="mpph.REF.nellist.2015.467">Nellist et al 2015</xref>].</p>
            <p><bold>Tone abnormalities,</bold> particularly hypotonia, are present at birth in most infants. Although tone may improve with age, several older individuals have remained severely hypotonic.</p>
            <p><bold>Intellectual disability.</bold> Almost all reported individuals with MPPH syndrome have intellectual disability that ranges from mild to severe. The degree of intellectual disability is largely determined by the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Extent and severity of the cortical malformations (i.e., severity and distribution of PMG) (see <xref ref-type="sec" rid="mpph.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</xref>)</p>
              </list-item>
              <list-item>
                <p>Age of onset and severity of epilepsy. Early-onset epilepsy (particularly in the newborn period), and generalized epilepsy are typically associated with more severe developmental and cognitive issues.</p>
              </list-item>
            </list>
          </sec>
          <sec id="mpph.Other_Findings">
            <title>Other Findings</title>
            <p><bold>Postaxial polydactyly</bold> involving from one to all four extremities has been reported in 50% of children with MPPH syndrome.</p>
            <p>
              <bold>Additional clinical features</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>
                  <bold>Common</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Feeding difficulties (occasionally requiring gastrostomy tube placement)</p>
                  </list-item>
                  <list-item>
                    <p>Visual problems (including cortical visual impairment and blindness)</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>
                  <bold>Seen in &#x0003c;5 individuals each</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Congenital cardiovascular defects (including ventricular septal defect, atrial septal defect)</p>
                  </list-item>
                  <list-item>
                    <p>Thyroid problems (including hypothyroidism, Hashimoto thyroiditis)</p>
                  </list-item>
                  <list-item>
                    <p>Renal anomalies (e.g., duplicated renal collecting system)</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>
                  <bold>Seen in one individual only</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Medulloblastoma [<xref ref-type="bibr" rid="mpph.REF.osterling.2011.370">Osterling et al 2011</xref>]</p>
                  </list-item>
                  <list-item>
                    <p>Encephalocele, cleft palate, and multiple polyps of the tongue [<xref ref-type="bibr" rid="mpph.REF.demir.2015.381">Demir et al 2015</xref>]</p>
                  </list-item>
                </list>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="mpph.Phenotype_Correlations_by_Gene">
          <title>Phenotype Correlations by Gene</title>
          <p><bold><italic toggle="yes">AKT3.</italic></bold> Features including connective tissue laxity and cutaneous capillary malformations can overlap with the megalencephaly-capillary malformation (MCAP) syndrome (see <xref ref-type="sec" rid="mpph.Differential_Diagnosis">Differential Diagnosis</xref>) [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.nakamura.2014.396">Nakamura et al 2014</xref>, <xref ref-type="bibr" rid="mpph.REF.nellist.2015.467">Nellist et al 2015</xref>].</p>
          <p><bold><italic toggle="yes">CCND2</italic>.</bold> Polymicrogyria (PMG) appears to be more severe and widespread, typically extending to the frontal and/or occipital lobes. These extensive cortical malformations correlate with increased severity of epilepsy and intellectual disability [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</xref>].</p>
          <p>Postaxial polydactyly is more commonly observed than with mutation of either <italic toggle="yes">PIK3R2</italic> or <italic toggle="yes">AKT3</italic> [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</xref>].</p>
        </sec>
        <sec id="mpph.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>In general no differences in phenotype have been observed between individuals with a molecularly confirmed diagnosis and those with a clinical diagnosis only. The exceptions are several individuals with a molecularly confirmed diagnosis of MPPH syndrome who had bilateral perisylvian polymicrogyria but lacked the core clinical feature of megalencephaly [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>].</p>
        </sec>
        <sec id="mpph.Penetrance">
          <title>Penetrance</title>
          <p>Although penetrance for MPPH syndrome is expected to be high, to date it cannot be definitively determined to be 100% due to the identification of low-level mosaic somatic <italic toggle="yes">PIK3R2</italic> pathogenic variants in individuals who have only one of the core features (i.e., bilateral perisylvian polymicrogyria) [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>].</p>
        </sec>
        <sec id="mpph.Prevalence">
          <title>Prevalence</title>
          <p>MPPH syndrome has been reported to date in 62 individuals from various ethnic backgrounds. Therefore, data regarding prevalence are limited.</p>
        </sec>
      </sec>
      <sec id="mpph.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><xref ref-type="table" rid="mpph.T.allelic_disorders">Table 2</xref> includes other phenotypes caused by pathogenic variants in the genes associated with MPPH syndrome. Of note, the phenotypic spectrum associated with variants in the three MPPH-related genes will likely continue to expand, at least in part due to the phenotypic variability observed with somatic mosaicism.</p>
        <table-wrap id="mpph.T.allelic_disorders" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Allelic Disorders</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mpph.T.allelic_disorders_1_1_1_1" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Gene</th>
                <th id="hd_h_mpph.T.allelic_disorders_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotype</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                  <italic toggle="yes">AKT3</italic>
                </td>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" rowspan="3" valign="middle" align="left" colspan="1">Gain-of-function variants</td>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Hemimegalencephaly (HMEG)&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Focal cortical dysplasia (FCD)</td>
              </tr>
              <tr>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Megalencephaly (MEG)</td>
              </tr>
              <tr>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Loss-of-function variants&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Microcephaly and intellectual disability&#x000a0;<sup>3</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">CCND2</italic>
                </td>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">None</td>
              </tr>
              <tr>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">PIK3R2</italic>
                </td>
                <td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Bilateral perisylvian polymicrogyria (BPP)&#x000a0;<sup>4</sup></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="mpph.TF.2.1">
              <label>1. </label>
              <p>Two individuals with hemimegalencephaly with the same mosaic <italic toggle="yes">AKT3</italic> pathogenic variant (p.Glu17Lys; detectable in brain tissue only) have been reported. The paralogous <italic toggle="yes">AKT1</italic> pathogenic variant (the equivalent change in a related gene) is associated with <related-object link-type="booklink" source-id="gene" document-id="proteus" document-type="chapter">Proteus syndrome</related-object> [<xref ref-type="bibr" rid="mpph.REF.lindhurst.2011.611">Lindhurst et al 2011</xref>].</p>
            </fn>
            <fn id="mpph.TF.2.2">
              <label>2. </label>
              <p>Deletions resulting in presumed loss of function</p>
            </fn>
            <fn id="mpph.TF.2.3">
              <label>3. </label>
              <p><xref ref-type="bibr" rid="mpph.REF.ballif.2012.145">Ballif et al [2012]</xref>, <xref ref-type="bibr" rid="mpph.REF.nagamani.2012.176">Nagamani et al [2012]</xref>, <xref ref-type="bibr" rid="mpph.REF.gai.2015.174">Gai et al [2015]</xref></p>
            </fn>
            <fn id="mpph.TF.2.4">
              <label>4. </label>
              <p>
                <xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al [2015]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="mpph.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <table-wrap id="mpph.T.disorders_to_consider_in_the_diff" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of MPPH Syndrome</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1">Disorder</th>
                <th id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2">Gene</th>
                <th id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3">MOI</th>
                <th id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Clinical Features of the Disorder</th>
              </tr>
              <tr>
                <th headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Also in MPPH syndrome</th>
                <th headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Not in MPPH syndrome</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">MCAP syndrome (see <related-object link-type="booklink" source-id="gene" document-id="pik3ca-overgrowth" document-type="chapter"><italic toggle="yes">PIK3CA</italic>-Related Segmental Overgrowth</related-object>)</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PIK3CA</italic>
                </td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">De novo</italic> / mosaic&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>MEG (congenital or postnatal)</p></list-item><list-item><p>BPP</p></list-item><list-item><p>Postaxial polydactyly</p></list-item><list-item><p>Ventriculomegaly or hydrocephalus</p></list-item></list>
</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Somatic vascular malformations (capillary malformations, often multiple)</p></list-item><list-item><p>Somatic overgrowth (focal segmental)</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN </italic>hamartoma tumor syndrome</related-object>
                </td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PTEN</italic>
                </td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">De novo</italic> / AD</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>MEG (congenital or postnatal)</p></list-item><list-item><p>Focal segmental cortical malformations (rare)</p></list-item></list>
</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Papillomatous papules</p></list-item><list-item><p>Trichilemmomas</p></list-item><list-item><p>Vascular malformations (hemangiomas, arteriovenous malformations)</p></list-item><list-item><p>Increased cancer predisposition (thyroid, breast, endometrium)</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">MTOR</italic>-related disorders&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MTOR</italic>
                </td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">De novo</italic> / mosaic</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>MEG (congenital or postnatal)</p></list-item></list>
</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>FCD</p></list-item><list-item><p>Pigmentary mosaicism&#x000a0;<sup>2</sup></p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">STRADA</italic>-related disorders (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/611087">OMIM</ext-link>)</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">STRADA</italic> (<italic toggle="yes">LYK5</italic>)</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>MEG (congenital or postnatal)</p></list-item><list-item><p>Early-onset epilepsy</p></list-item></list>
</td>
                <td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Early lethality</p></list-item><list-item><p>Uniformly poor neurodevelopmental outcome</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode(s) of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
            <fn>
              <p>AR = autosomal recessive</p>
            </fn>
            <fn>
              <p>MCAP = megalencephaly-capillary malformation</p>
            </fn>
            <fn>
              <p>MEG = megalencephaly</p>
            </fn>
            <fn>
              <p>BPP = bilateral perisylvian polymicrogyria</p>
            </fn>
            <fn>
              <p>FCD = focal cortical dysplasia</p>
            </fn>
            <fn id="mpph.TF.3.1">
              <label>1. </label>
              <p>MCAP is not typically inherited; to date most affected individuals (21/24) had somatic mosaicism for a <italic toggle="yes">PIK3CA</italic> pathogenic variant, suggesting that the variant occurred post-fertilization in one cell of the multicellular embryo.</p>
            </fn>
            <fn id="mpph.TF.3.2">
              <label>2. </label>
              <p>
                <xref ref-type="bibr" rid="mpph.REF.mirzaa.2016.836">Mirzaa et al [2016]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="mpph.Management">
        <title>Management</title>
        <sec id="mpph.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with megalencephaly-postaxial polydactyly-polymicrogyria-hydrocephalus (MPPH) syndrome, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical examination with particular attention to head size (OFC)</p>
            </list-item>
            <list-item>
              <p>In the presence of hydrocephalus and/or cerebellar tonsillar ectopia, full spinal MRI to evaluate for syringomyelia or syrinx formation</p>
            </list-item>
            <list-item>
              <p>Assessment by a pediatric neurologist with evaluation of suspected seizures as indicated</p>
            </list-item>
            <list-item>
              <p>Assessment of feeding by a feeding specialist, nutritionist, and gastroenterologist for evidence of chewing and swallowing difficulties and dysphagia</p>
            </list-item>
            <list-item>
              <p>Developmental assessment</p>
            </list-item>
            <list-item>
              <p>Echocardiogram (to evaluate for structural cardiac defects)</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound examination (to evaluate for structural renal defects)</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="mpph.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Neurosurgical complications (hydrocephalus and cerebellar tonsillar ectopia).</bold> Findings warranting neurosurgical referral include rapidly enlarging OFC, obstructive hydrocephalus, symptoms of increased intracranial pressure, and progressive or symptomatic cerebellar tonsillar ectopia (CBTE) or Chiari malformation. Early treatment of hydrocephalus may reduce the risk for progressive CBTE, but data to determine the most appropriate neurosurgical management are lacking.</p>
          <p><bold>Feeding difficulties such as</bold> chewing and swallowing difficulties and dysphagia require evaluation by a feeding specialist and/or gastroenterologist to promote early identification and prompt intervention which may include dietary modification and/or placement of a gastrostomy (G) tube.</p>
          <p>Speech therapy is indicated for difficulties with speech, swallowing, and feeding.</p>
          <p><bold>Epilepsy</bold> may require long-term antiepileptic treatment.</p>
          <p><bold>Developmental delays.</bold> Initiation of physical, occupational, and speech therapy is recommended within the first year of life.</p>
        </sec>
        <sec id="mpph.Surveillance">
          <title>Surveillance</title>
          <p>Given the limited number of individuals reported with MPPH syndrome, no formal surveillance guidelines exist; however, recommended surveillance includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Follow-up with a pediatric neurologist, at least every six months until age six years, and annually thereafter.</p>
            </list-item>
            <list-item>
              <p>Brain MRI to detect hydrocephalus and/or cerebellar tonsillar ectopia; provisionally recommended every six months from birth to age two years, and annually from age two to six years. In older individuals, the frequency should be based on prior results and clinical findings, with particular attention to apnea or other abnormal patterns of respiration, headaches, changes in gait, or other neurologic problems.</p>
            </list-item>
            <list-item>
              <p>Long-term neurologic follow up is recommended for management of epilepsy.</p>
            </list-item>
            <list-item>
              <p>Routine follow up with a developmental pediatrician is appropriate, given the high risk for developmental delays and/or intellectual disability.</p>
            </list-item>
          </list>
        </sec>
        <sec id="mpph.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="mpph.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mpph.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="mpph.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mpph.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>MPPH syndrome is expressed in an autosomal dominant manner.</p>
        </sec>
        <sec id="mpph.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Ninety-nine percent of individuals with MPPH syndrome have the disorder as the result of a <italic toggle="yes">de novo AKT3</italic>, <italic toggle="yes">CCND2</italic>, or <italic toggle="yes">PIK3R2</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Vertical transmission of a <italic toggle="yes">PIK3R2</italic> pathogenic variant has been reported in one family to date (a heterozygous parent and several children were affected) [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>Parental germline mosaicism was suggested in two families by recurrence of MMPH syndrome in sibs and failure to detect the pathogenic variant in DNA isolated from parental blood samples [<xref ref-type="bibr" rid="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing for the pathogenic variant identified in the proband and a baseline neurologic assessment including measurement of head size.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband is not detected in leukocyte DNA of either parent, the proband most likely has a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
              <p>Another possible explanation is germline mosaicism in a parent. Parental germline mosaicism was suggested in two families by recurrence of a <italic toggle="yes">PIK3R2</italic> pathogenic variant in sibs whose parents did not have the variant in blood DNA [<xref ref-type="bibr" rid="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>].</p>
            </list-item>
          </list>
          <p>Note: If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic (and germline) mosaicism for the variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%. While there may be phenotypic variability within the same family, all sibs who inherit a pathogenic variant will have features of MPPH syndrome.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">AKT3</italic>, <italic toggle="yes">CCND2</italic>, or <italic toggle="yes">PIK3R2</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (but as-yet unknown) because of the possibility of parental germline mosaicism; further data are necessary to establish the recurrence risk for sibs.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with a germline <italic toggle="yes">AKT3</italic>, <italic toggle="yes">CCND2</italic>, or <italic toggle="yes">PIK3R2</italic> pathogenic variant has a 50% chance of inheriting the pathogenic variant; while there may be phenotypic variability within the same family, all offspring who inherit a pathogenic variant will have features of MPPH syndrome.</p>
            </list-item>
            <list-item>
              <p>The risk for transmission to offspring of an individual with somatic mosaicism for an MPPH-related pathogenic variant (i.e., the pathogenic variant is thought to have occurred post-fertilization in one cell of the multicellular embryo) is expected to be less than 50%.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent has a germline <italic toggle="yes">AKT3</italic>, <italic toggle="yes">CCND2</italic>, or <italic toggle="yes">PIK3R2</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="mpph.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic> (or, in rare cases, a parent may have germline mosaicism). However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to parents of affected individuals.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mpph.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">AKT3, CCND2,</italic> or <italic toggle="yes">PIK3R2</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for MPPH syndrome are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="mpph.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mpph.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="mpph.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">AKT3</italic>, <italic toggle="yes">CCND2</italic>, and <italic toggle="yes">PIK3R2</italic> encode key proteins within the phosphatidylinositol-4,5-bisphosphate-3-kinase (PI3K)-protein kinase B (AKT)-mammalian target of rapamycin (mTOR) pathway, a major signaling pathway involved with key cellular functions including protein synthesis, metabolism, cell cycle, survival, growth, and proliferation [<xref ref-type="bibr" rid="mpph.REF.engelman.2006.606">Engelman et al 2006</xref>, <xref ref-type="bibr" rid="mpph.REF.vanhaesebroeck.2012.195">Vanhaesebroeck et al 2012</xref>].</p>
          <p>Gain-of-function variants in these and other genes within the pathway (including <italic toggle="yes">PIK3CA</italic> and <italic toggle="yes">MTOR</italic>) are associated with a spectrum of diffuse and segmental developmental brain disorders including megalencephaly, hemimegalencephaly, polymicrogyria, and focal cortical dysplasia [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2014.156">Mirzaa &#x00026; Poduri 2014</xref>].</p>
          <p>AKT3 is a serine/threonine kinase and the principal target of phosphatidylinositol 3,4,5-trisphosphate (PIP3). <italic toggle="yes">PIK3R2</italic> encodes the beta regulatory subunit of the PI3K enzymatic complex, a kinase complex that phosphorylates phosphatidylinositol 4,5-bisphosphate, to generate PIP3. Binding of PIP3 to the AKT complex leads to phosphorylation of multiple downstream PI3K-AKT-MTOR targets, including MTOR (mammalian target of rapamycin) itself.</p>
          <p>CCND2, a protein that mediates the G1-S transition of the cell cycle, is among the downstream targets of the PI3K-AKT-MTOR pathway [<xref ref-type="bibr" rid="mpph.REF.engelman.2006.606">Engelman et al 2006</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</xref>].</p>
          <sec id="mpph.AKT3">
            <title>
              <italic toggle="yes">AKT3</italic>
            </title>
            <p><bold>Gene structure.</bold> The V-Akt murine thymoma viral oncogene homolog 3 encodes the serine/threonine kinase, AKT3. <italic toggle="yes">AKT3</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005465.4">NM_005465.4</ext-link>) comprises 13 coding exons.</p>
            <p><bold>Pathogenic variants.</bold> To date, three <italic toggle="yes">AKT3</italic> gain-of-function missense variants have been reported (see <xref ref-type="table" rid="mpph.T.akt3_variants_discussed_in_this_g">Table 4</xref>) [<xref ref-type="bibr" rid="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.nakamura.2014.396">Nakamura et al 2014</xref>, <xref ref-type="bibr" rid="mpph.REF.nellist.2015.467">Nellist et al 2015</xref>]. Data suggest that the mutational spectrum is broader [unpublished data].</p>
            <table-wrap id="mpph.T.akt3_variants_discussed_in_this_g" orientation="portrait" position="anchor">
              <label>Table 4. </label>
              <caption>
                <p><italic toggle="yes">AKT3</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.548T&#x0003e;A</td>
                    <td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val183Asp</td>
                    <td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005465.4">NM_005465.4</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.686A&#x0003e;G</td>
                    <td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn229Ser</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1393C&#x0003e;T</td>
                    <td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg465Trp</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">AKT3</italic> encodes 479 amino acids of the v-AKT murine thymoma viral oncogene homolog 3 or RAC-gamma serine/threonine protein kinase. AKT3 is a key regulator of PI3K-AKT-MTOR pathway function including metabolism, proliferation, cell survival, growth, and angiogenesis. AKT3 is highly expressed in brain lung and kidney. It is composed of three functional domains (PH, kinase and C-terminal domains).</p>
            <p><bold>Abnormal gene product.</bold> Gain-of-function pathogenic variants in <italic toggle="yes">AKT3</italic> lead to higher levels of phosphorylation of PI3K-AKT-MTOR pathway target proteins [<xref ref-type="bibr" rid="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>]. Further, in a study of malformations associated with focal cortical epilepsy caused by the p.Glu17Lys <italic toggle="yes">AKT3</italic> pathogenic variant, p.Glu17Lys expressing neural progenitors caused a non-cell autonomous migration defect in neighboring cells. Treatments aimed at either blocking downstream AKT signaling or inactivating AKT targets restored migration, suggesting that PI3K-AKT-MTOR pathway inhibitors may be potential treatments for some forms of focal epilepsy [<xref ref-type="bibr" rid="mpph.REF.baek.2015.1445">Baek et al 2015</xref>].</p>
            <p><bold>Cancer and benign tumors.</bold> AKT3 is a key modulator of several sporadic tumors (including melanoma, glioma, and ovarian cancer) that occur in the absence of any other findings of MPPH syndrome. Somatic gain-of-function missense variants across all functional domains of <italic toggle="yes">AKT3</italic> are seen in a variety of tumors in the Catalogue of Somatic Mutations in Cancer (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cancer.sanger.ac.uk/cosmic/">COSMIC</ext-link>). These somatic variants in <italic toggle="yes">AKT3</italic> are <bold>not</bold> present in the germline; thus, predisposition to these tumors is not heritable.</p>
          </sec>
          <sec id="mpph.CCND2">
            <title>
              <italic toggle="yes">CCND2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CCND2</italic> encodes the cyclin D2 protein that regulates the G1-S transition of the cell cycle. <italic toggle="yes">CCND2</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001759.3">NM_001759.3</ext-link>) comprises five coding exons.</p>
            <p><bold>Pathogenic variants.</bold> To date, seven <italic toggle="yes">CCND2</italic> missense variants involving four amino acid residues have been reported. All are within exon 5, the terminal exon of the gene.</p>
            <table-wrap id="mpph.T.ccnd2_pathogenic_variants_discuss" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p><italic toggle="yes">CCND2</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.808A&#x0003e;T</td>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys270Ter</td>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_3" rowspan="7" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001759.3">NM_001759.3</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.838A&#x0003e;G</td>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr280Ala</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.839C&#x0003e;A</td>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr280Asn</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.842C&#x0003e;G</td>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro281Arg</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.842C&#x0003e;T</td>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro281Leu</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.841C&#x0003e;T</td>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro281Ser</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.851T&#x0003e;G</td>
                    <td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val284Gly</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">CCND2</italic> encodes 289 amino acids of the cyclin D2 protein, which is a regulatory component of the cyclin D2-CDK4 (DC) complex. This complex phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G1-S transition.</p>
            <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">CCND2</italic> pathogenic variants cause accumulation of degradation-resistant CCND2. Specifically, the amino acid residue p.Thr280 has been shown to be the site for GSK-3&#x003b2; mediated phosphorylation, which triggers ubiquitin-mediated degradation of CCND2. Therefore, pathogenic variants abolishing this phosphorylation site result in accumulation of degradation-resistant cyclin D2, cell cycle progression, and increased neuronal proliferation [<xref ref-type="bibr" rid="mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</xref>].</p>
            <p><bold>Cancer and benign tumors.</bold> Sporadic tumors (including ovarian and testicular tumors) occurring in the absence of any other findings of MPPH syndrome have shown high level expression of <italic toggle="yes">CCND2</italic>. These somatic variants are <bold>not</bold> present in the germline; thus, predisposition to these tumors is not heritable. CCND2 is also overexpressed in astrocytomas and glioblastomas [<xref ref-type="bibr" rid="mpph.REF.parry.2012">Parry &#x00026; Engh 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.koyamanasu.2013.3840">Koyama-Nasu et al 2013</xref>].</p>
          </sec>
          <sec id="mpph.PIK3R2">
            <title>
              <italic toggle="yes">PIK3R2</italic>
            </title>
            <p><bold>Gene structure.</bold> The phosphatidylinositol 3-kinase &#x003b2; regulatory subunit (PIK3R2) encodes a lipid kinase within the PI3K enzymatic complex. <italic toggle="yes">PIK3R2</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005027.2">NM_005027.2</ext-link>) comprises 15 coding exons.</p>
            <p><bold>Pathogenic variants.</bold> To date, 33 of the 35 published incidences of <italic toggle="yes">PIK3R2</italic> pathogenic variants are a single recurrent variant (p.Gly373Arg) within the first sequence homology (SH) domain of the protein [<xref ref-type="bibr" rid="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>, <xref ref-type="bibr" rid="mpph.REF.nakamura.2014.396">Nakamura et al 2014</xref>, <xref ref-type="bibr" rid="mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</xref>, <xref ref-type="bibr" rid="mpph.REF.terrone.2016.1359">Terrone et al 2016</xref>].</p>
            <table-wrap id="mpph.T.pik3r2_pathogenic_variants_discus" orientation="portrait" position="anchor">
              <label>Table 6. </label>
              <caption>
                <p><italic toggle="yes">PIK3R2</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1117G&#x0003e;A</td>
                    <td headers="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly373Arg</td>
                    <td headers="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005027.2">NM_005027.2</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">PIK3R2</italic> encodes the regulatory subunit of the PI3K enzymatic complex, a kinase that phosphorylates PtdIns (4,5) P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 recruits PH domain-containing proteins to the membrane, including AKT and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility, and morphology [<xref ref-type="bibr" rid="mpph.REF.engelman.2006.606">Engelman et al 2006</xref>]. PIK3R2 binds to activated (phosphorylated) protein-tyrosine kinases through its SH2 domain and acts as an adapter, mediating the association of the p110 catalytic unit with the plasma membrane.</p>
            <p><bold>Abnormal gene product.</bold> The recurrent <italic toggle="yes">PIK3R2</italic> pathogenic variant, p.Gly373Arg, causes hyperactivation of PI3K-AKT-MTOR pathway downstream targets [<xref ref-type="bibr" rid="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>].</p>
            <p><bold>Cancer and benign tumors.</bold> Somatic gain-of-function pathogenic variants in <italic toggle="yes">PIK3R2</italic> occur in sporadic tumors, particularly endometrial cancer in the absence of any other findings of MPPH syndrome. These somatic <italic toggle="yes">PIK3R2</italic> variants are <bold>not</bold> present in the germline; thus, predisposition to these tumors is not heritable.</p>
          </sec>
        </sec>
      </sec>
      <sec id="mpph.References">
        <title>References</title>
        <sec id="mpph.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mpph.Literature_Cited.reflist0">
            <ref id="mpph.REF.baek.2015.1445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baek</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yun</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwon</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guemez-Gamboa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathern</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleeson</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <article-title>An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development.</article-title>
                <source>Nat Med.</source>
                <year>2015</year>
                <volume>21</volume>
                <fpage>1445</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">26523971</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.ballif.2012.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ballif</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenfeld</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traylor</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theisen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bader</surname>
                    <given-names>PI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ladda</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sell</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinraths</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surti</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuire</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schnur</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coffey</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tervo</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroud</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marble</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Netzloff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aylsworth</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamforth</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niyazov</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravnan</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultz</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamb</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torchia</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bejjani</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <article-title>High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44.</article-title>
                <source>Hum Genet.</source>
                <year>2012</year>
                <volume>131</volume>
                <fpage>145</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">21800092</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.chung.2014.1868">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eydoux</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Karnebeek</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>WT</given-names>
                  </name>
                </person-group>
                <article-title>Duplication of AKT3 is associated with macrocephaly and speech delay.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2014</year>
                <volume>164A</volume>
                <fpage>1868</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24700746</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.colombani.2006.466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colombani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chouchane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pitelet</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinard</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lion-Fran&#x000e7;ois</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thauvin-Robinet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mugneret</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guibaud</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>A new case of megalencephaly and perisylvian polymicrogyria with post-axial polydactyly and hydrocephalus: MPPH syndrome.</article-title>
                <source>Eur J Med Genet.</source>
                <year>2006</year>
                <volume>49</volume>
                <fpage>466</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">16807158</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.conti.2015.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pantaleo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barba</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baroni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buccoliero</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giglio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baek</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleeson</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1-q44 duplication including the AKT3 gene.</article-title>
                <source>Clin Genet.</source>
                <year>2015</year>
                <volume>88</volume>
                <fpage>241</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25091978</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.demir.2015.381">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Demir</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peker</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000fc;l&#x0015f;en</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaba</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuncer</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly, polymicrogyria, polydactyly and hydrocephalus (mpph) syndrome: a new case with occipital encephalocele and cleft palate.</article-title>
                <source>Genet Couns.</source>
                <year>2015</year>
                <volume>26</volume>
                <fpage>381</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">26852507</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.engelman.2006.606">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engelman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantley</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.</article-title>
                <source>Nat Rev Genet.</source>
                <year>2006</year>
                <volume>7</volume>
                <fpage>606</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">16847462</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.gai.2015.174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gai</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypes of AKT3 deletion: a case report and literature review.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2015</year>
                <volume>167A</volume>
                <fpage>174</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25424989</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.garavelli.2007.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garavelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guareschi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Errico</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergonzini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zollino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Der Spek</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frigieri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zonari</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giustina</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amarri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banchini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus (MPPH): report of a new case.</article-title>
                <source>Neuropediatrics.</source>
                <year>2007</year>
                <volume>38</volume>
                <fpage>200</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18058629</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.harada.2015.465">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harada</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miya</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Utsunomiya</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamanaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsunoda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanemura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamasaki</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Sudden death in a case of megalencephaly capillary malformation associated with a de novo mutation in AKT3.</article-title>
                <source>Childs Nerv Syst.</source>
                <year>2015</year>
                <volume>31</volume>
                <fpage>465</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">25416470</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.hemming.2016.458">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hemming</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forrest</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shipman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravine</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heng</surname>
                    <given-names>JI</given-names>
                  </name>
                </person-group>
                <article-title>Reinforcing the association between distal 1q CNVs and structural brain disorder: A case of a complex 1q43-q44 CNV and a review of the literature.</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet.</source>
                <year>2016</year>
                <volume>171B</volume>
                <fpage>458</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">26853090</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.jamuar.2014.733">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jamuar</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kircher</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Gama</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barry</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Partlow</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servattalab</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topcu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amrom</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parrini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leventer</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkovich</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nickerson</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shendure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poduri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Somatic mutations in cerebral cortical malformations.</article-title>
                <source>N Engl J Med.</source>
                <year>2014</year>
                <volume>371</volume>
                <fpage>733</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">25140959</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.kariminejad.2013.651">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kariminejad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radmanesh</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezayi</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonekaboni</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleeson</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome: a case report.</article-title>
                <source>J Child Neurol.</source>
                <year>2013</year>
                <volume>28</volume>
                <fpage>651</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22859694</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.koyamanasu.2013.3840">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koyama-Nasu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nasu-Nishimura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Todo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ino</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aburatani</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funato</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echizen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugano</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haruta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manabe</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells.</article-title>
                <source>Oncogene.</source>
                <year>2013</year>
                <volume>32</volume>
                <fpage>3840</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22964630</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.lindhurst.2011.611">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindhurst</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sapp</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teer</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finn</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannons</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bick</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakemore</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blumhorst</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calder</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cherman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deardorff</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Everman</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenstein</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keppler-Noreuil</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuznetsov</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rothenberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singhal</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tirabosco</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Upton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wientroub</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoag</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitewood-Neal</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robey</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzberg</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darling</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tosi</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullikin</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <article-title>A mosaic activating mutation in AKT1 associated with the Proteus syndrome.</article-title>
                <source>N Engl J Med.</source>
                <year>2011</year>
                <volume>365</volume>
                <fpage>611</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21793738</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.mirzaa.2004.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dodge</surname>
                    <given-names>NN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glass</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Day</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gripp</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus: a rare brain malformation syndrome associated with mental retardation and seizures.</article-title>
                <source>Neuropediatrics.</source>
                <year>2004</year>
                <volume>35</volume>
                <fpage>353</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15627943</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.mirzaa.2016.836">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solovieff</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goold</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timms</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biag</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olds</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishak</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poliachik</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girisha</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeung</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahikkala</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunter</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDaniel</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macmurdo</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leary</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weaver</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorschner</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhangiani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muzny</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerwinkle</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shendure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saneto</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novotny</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sellers</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrissey</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hevner</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ojemann</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>LO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winckler</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism.</article-title>
                <source>JAMA Neurol.</source>
                <year>2016</year>
                <volume>73</volume>
                <fpage>836</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">27159400</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.mirzaa.2015.1182">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timms</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smyser</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnett</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hufnagel</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narumi-Kishimoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olds</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deleuze</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nitschk&#x000e9;</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friend</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goetsch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parrini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tattini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slavotinek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blair</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shendure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chelly</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study.</article-title>
                <source>Lancet Neurol.</source>
                <year>2015</year>
                <volume>14</volume>
                <fpage>1182</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">26520804</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.mirzaa.2012.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gripp</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>deVries</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>269</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">22228622</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.mirzaa.2014.510">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fry</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giamanco</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanstone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Logan</surname>
                    <given-names>CV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kholmanskikh</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodge</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hevner</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonthron</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivi&#x000e8;re</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St-Onge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gripp</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Esch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verbeek</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieczorek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinraths</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <collab>FORGE Canada Consortium</collab>
                </person-group>
                <article-title>Boycott KM, Pilz DT, Ross ME, Dobyns WB, Sheridan EG. De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.</article-title>
                <source>Nat Genet.</source>
                <year>2014</year>
                <volume>46</volume>
                <fpage>510</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24705253</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.mirzaa.2014.156">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poduri</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology.</article-title>
                <source>Am J Med Genet C Semin Med Genet.</source>
                <year>2014</year>
                <volume>166C</volume>
                <fpage>156</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">24888963</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.nagamani.2012.176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nagamani</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pettigrew</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalani</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowaczyk</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proud</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craigen</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plunkett</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hixson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stankiewicz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>SW</given-names>
                  </name>
                </person-group>
                <article-title>Delineation of a deletion region critical for corpus callosal abnormalities in chromosome 1q43-q44.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2012</year>
                <volume>20</volume>
                <fpage>176</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21934713</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.nakamura.2014.396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tohyama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiohama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayasaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishiyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kodera</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakashima</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsurusaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitsu</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH.</article-title>
                <source>Clin Genet.</source>
                <year>2014</year>
                <volume>85</volume>
                <fpage>396</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23745724</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.nellist.2015.467">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nellist</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogeveen-Westerveld</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuteboom</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Louw</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lequin</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindels-de Heus</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sibbles</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <article-title>Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2015</year>
                <volume>114</volume>
                <fpage>467</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">25523067</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.osterling.2011.370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Osterling</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyer</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedlund</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bale</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <article-title>Jr. MPPH syndrome: two new cases.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2011</year>
                <volume>44</volume>
                <fpage>370</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">21481746</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.parry.2012">
              <mixed-citation publication-type="other">Parry PV, Engh JA. The role of cyclin-d2 in the tumorigenesis of glioblastoma. Neurosurgery. 2012; 71:N22-3.</mixed-citation>
            </ref>
            <ref id="mpph.REF.pisano.2008.916">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pisano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meloni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cianchetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nucaro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruna</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly, polymicrogyria, and hydrocephalus (MPPH) syndrome: a new case with syndactyly.</article-title>
                <source>J Child Neurol</source>
                <year>2008</year>
                <volume>23</volume>
                <fpage>916</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18474936</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.poduri.2012.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poduri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evrony</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elhosary</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beroukhim</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehtinen</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hills</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinzen</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barry</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourgeois</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riviello</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkovich</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ligon</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Somatic activation of AKT3 causes hemispheric developmental brain malformations.</article-title>
                <source>Neuron.</source>
                <year>2012</year>
                <volume>74</volume>
                <fpage>41</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22500628</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.rivi_re.2012.934">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rivi&#x000e8;re</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Roak</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beddaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alcantara</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St-Onge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gripp</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikkel</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Worthylake</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albrecht</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armour</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caluseriu</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cytrynbaum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drolet</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Innes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lauzon</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschino</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reggin</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saggar</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uyanik</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zirn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaulieu</surname>
                    <given-names>CL</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>934</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">22729224</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.tapper.2014.e86940">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tapper</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulds</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cross</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aranaz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Score</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hidalgo-Curtis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ennis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations.</article-title>
                <source>PloS One.</source>
                <year>2014</year>
                <volume>9</volume>
                <fpage>e86940</fpage>
                <pub-id pub-id-type="pmid">24497998</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.terrone.2016.1359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Terrone</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voisin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdullah Alfaiz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappuccio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vitiello</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guex</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Amico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James Barkovich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunetti-Pierri</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Giudice</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reymond</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>De novo PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2016</year>
                <volume>24</volume>
                <fpage>1359</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">26860062</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.tohyama.2007.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tohyama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akasaka</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishiyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly and polymicrogyria with polydactyly syndrome.</article-title>
                <source>Pediatr Neurol</source>
                <year>2007</year>
                <volume>37</volume>
                <fpage>148</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">17675034</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.tore.2009.1620">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tore</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKinney</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagar</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Truwit</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raybaud</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Syndrome of megalencephaly, polydactyly, and polymicrogyria lacking frank hydrocephalus, with associated MR imaging findings.</article-title>
                <source>AJNR Am J Neuroradiol.</source>
                <year>2009</year>
                <volume>30</volume>
                <fpage>1620</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">19369601</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.vanhaesebroeck.2012.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanhaesebroeck</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephens</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawkins</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>PI3K signalling: the path to discovery and understanding.</article-title>
                <source>Nat Rev Mol Cell Biol.</source>
                <year>2012</year>
                <volume>13</volume>
                <fpage>195</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">22358332</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.verkerk.2010.1488">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verkerk</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Waterschoot</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douben</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poddighe</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lequin</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terhal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnemann</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Wit</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wafelman</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garavelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van der Spek</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Klein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <article-title>Unbalanced der(5)t(5;20) translocation associated with megalencephaly, perisylvian polymicrogyria, polydactyly and hydrocephalus.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>1488</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">20503325</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.wang.2013.2016">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeesman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarnopolsky</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowaczyk</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Duplication of AKT3 as a cause of macrocephaly in duplication 1q43q44.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2013</year>
                <volume>161A</volume>
                <fpage>2016</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23794269</pub-id>
              </element-citation>
            </ref>
            <ref id="mpph.REF.zamora.2013">
              <mixed-citation publication-type="other">Zamora TG, Roberts KD. Four-year follow-up of megalencephaly, polymicrogyria, postaxial polydactyly and hydrocephalus (MPPH) syndrome. BMJ Case Rep. 2013;2013.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mpph.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mpph.Author_Notes">
          <title>Author Notes</title>
          <p>Dr Ghayda Mirzaa is a physician scientist at the Seattle Children&#x02019;s Research Institute. Her research is focused on understanding the developmental basis and genetic causes of a wide range of developmental brain disorders, with a particular focus on brain growth problems including megalencephaly and microcephaly. Dr Mirzaa&#x02019;s research team studies the natural history of MPPH syndrome.</p>
        </sec>
        <sec id="mpph.Acknowledgments">
          <title>Acknowledgments</title>
          <p>We thank our patients and their families and health care providers for their collaboration and contribution to our knowledge about MPPH syndrome.</p>
        </sec>
        <sec id="mpph.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>17 November 2016 (bp) Review posted live</p>
            </list-item>
            <list-item>
              <p>31 March 2016 (gm) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
